Home › Funds › Moors & Cabot, Inc. › QGEN
Moors & Cabot, Inc. position in QGEN
QIAGEN NV · Health Care
Moors & Cabot, Inc. reported holding 250,461 shares of QGEN (QIAGEN NV) in its Q3 2026 13F filing — a position valued at US$11.0M, representing 0.44% of its reported portfolio and ranking #49 among its reported holdings. Moors & Cabot, Inc. has disclosed QGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Moors & Cabot, Inc.'s QGEN position evolved
Moors & Cabot, Inc. first disclosed a stake in QGEN in Q3 2023 at 88,630 shares (US$3.6M). The position peaked in Q3 2025 at 352,809 shares, worth US$15.8M. Across 13 filings, Moors & Cabot, Inc. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 250,461 shares valued at US$11.0M — a reduction of -89,000 shares quarter over quarter.. Notable position changes include a 137% increase in Q2 2025 (shares fell 7% over the following quarter), a 78% increase in Q3 2025 (shares were roughly flat over the following quarter), a 88% increase in Q2 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 88.63K | $3.59M | New |
| Q4 2023 | 88.66K | $3.85M | Hold |
| Q1 2024 | 86.05K | $3.70M | Reduce |
| Q2 2024 | 86.05K | $3.54M | Hold |
| Q3 2024 | 86.05K | $3.92M | Hold |
| Q4 2024 | 86.47K | $3.85M | Hold |
| Q1 2025 | 83.67K | $3.36M | Reduce |
| Q2 2025 | 197.96K | $9.51M | Add |
| Q3 2025 | 352.81K | $15.76M | Add |
| Q4 2025 | 330.75K | $14.87M | Reduce |
| Q1 2026 | 180.63K | $7.23M | Reduce |
| Q2 2026 | 339.46K | $13.27M | Add |
| Q3 2026 | 250.46K | $10.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QGEN and 13F data
QGEN (QIAGEN NV) is a Health Care company. 28 other funds we track also report a position in QGEN — the largest reported positions include Fivespan Partners, LP (US$237.6M), EARNEST PARTNERS LLC (US$203.6M), Helikon Investments Ltd (US$100.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QGEN
- Fivespan Partners, LP 5.43M sh · $237.58M · Q3 2026
- EARNEST PARTNERS LLC 4.65M sh · $203.58M · Q3 2026
- Helikon Investments Ltd 2.29M sh · $100.28M · Q3 2026
More on Moors & Cabot, Inc.
FAQ
How long has Moors & Cabot, Inc. held QGEN?
Moors & Cabot, Inc. has disclosed QGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Moors & Cabot, Inc.'s current position in QGEN?
As of Q3 2026, Moors & Cabot, Inc. holds 250.46K shares of QGEN (QIAGEN NV), valued at $10.96M, representing 0.44% of its reported portfolio and ranking #49.
Has Moors & Cabot, Inc. been buying or selling QGEN?
In the latest 13F filing (Q3 2026), Moors & Cabot, Inc. reduced its position in QGEN. The position peaked in Q3 2025 at 352.81K shares.
Which other funds hold QGEN?
Other major institutional holders of QGEN include Fivespan Partners, LP, EARNEST PARTNERS LLC, Helikon Investments Ltd, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.